1,061
Participants
Start Date
January 31, 2007
Primary Completion Date
March 31, 2009
Study Completion Date
March 31, 2009
Tigecycline
150 mg Tigecycline once-daily IV infusion for up to 28 days, or 42 days for the substudy wth osteomyelitis
Ertapenem
Ertapenem 1g IV infusion every 24 hours +/- vancomycin depending on culture results and at the discretion of investigator (for coverage of Methicillin-resistant Staphylococcus aureus (MRSA), coagulase-negative staphylococci (CNS) or enterococci coverage).
Pretoria
Rome
Panama City
Riga
Riga
Riga
Brussels
La Plata
Morón
Budapest
Brussels
Budapest
Brussels
Vienna
Buenos Aires
Buenos Aires
Adana
Buenos Aires
Benoni
Loma Hermosa
Ciudadela, 3 de Febrero
Merlo
La Plata
Rosario
Kiev
Kistarcsa
Kyiv
Copenhagen
Bornem
Melbourne
Paraná
Melbourne
Pellenberg
Liepāja
San Miguel de Tucumán
Debrecen
Córdoba
Odense
Córdoba
Córdoba
Mendoza
Tunuyán
Port Elizabeth
Chivilcoy
Palma de Mallorca
Mar del Plata
Székesfehérvár
Barcelona
Győr
Nové Zámky
Zagreb
Vilnius
Holargos, Athens
Tallinn
Cherkassy
Granada
West Reading
Bucharest
Turku
Vinnytsia
Baltimore
Winston-Salem
Madrid
Getafe Madrid
Columbia
Kohtla-Järve
Pensacola
Orlando
Orlando
West Palm Beach
Durango
Istanbul
Capa-Istanbul
Abano Terme (PD)
Panevezys
Giessen
Toledo
Guadalajara
Colonia El Ritiro
Bochum
Lima
Gelsenkirchen
Kaunas
Münster
Rheine
Dnipro
Kaunas
Tartu
Tartu
Pisa
Tourcoing
North Chicago
Evanston
Chicago
Springfield
Springfield
Strasbourg
Zaporizhzhya
Kuopio
Dallas
Šiauliai
San Luis Potosí City
San Antonio
Lviv
Hermosillo
Los Angeles
Torrance
Northridge
Los Angeles
Sylmar
Veracruz
Klaipėda
San Francisco
Honolulu
Banska.Bysterica
Beijing
Beijing
Moscow
Moscow
Moscow
Moscow
Moscow
Moscow
Harbin
Saint Petersburg
Saint Petersburg
Smolensk
Tianjin
Jaipur
Vadodara
Cluj-Napoca
Pune
Guangzhou
Bangalore
Bacau
Nizhny Novgorod
Nizhny Novgorod
Yekaterinburg
Novosibirsk
Omsk
Kemerovo
Lasi
Boston
Somers Point
Buenos Aires
Ciudadela, 3 de Febrero
La Plata
Loma Hermosa
Paraná
Buenos Aires
Córdoba
Córdoba
Rio de Janeiro
São Paulo
Vancouver
Winnipeg
Hamilton
Ottawa
Chicoutimi
Montreal
Sherbrooke
Trois-Rivières
Santiago
Valdivia
Bogotá
Yaroslavl
Tainan City
Taoyuan Hsien
Bogotá
Zadar
Zagreb
Athens
Rio-Patras
Budapest
Riga
Riga
Kaunas
Vilnius
Mendoza
Santa Fe
San Luis Potosí City
Lima
Lima
Bielsko-Biala
Cieszyn
Gdansk
Lodz
Warsaw
Wroclaw
Lisbon
Lisbon
Chelyabinsk
Banská Bystrica
Bratislava
Ľubochňa
Martin
Nitra
Gyeonggi-do
Seoul
Seoul
Seoul
Huddinge
Uppsala
Basel
Geneva
Kyiv
Wishaw
Birmingham
Birmingham
London
Oxford
Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY